Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking

W K Tonui1, P A Mbati, C O Anjili

  • 1Centre for Biotechnology Research and Development, Kenya Medical Research Institute, P.O. Box 54840, Nairobi, Kenya.

Abstract

Insights

Lipophosphoglycan (LPG) shows promise as a transmission-blocking vaccine candidate for leishmaniasis, significantly reducing parasite development in sandflies. This approach offers a new strategy against leishmaniasis, a disease with limited treatment options.

Area of Science:

  • Immunology
  • Parasitology
  • Vaccine Development

Background:

  • Current leishmaniasis chemotherapy is lengthy, costly, and has side effects.
  • Vector control is limited, and an effective vaccine is unavailable.
  • New strategies are urgently needed for leishmaniasis control.

Purpose of the Study:

  • To evaluate the inhibition of Leishmania promastigote development in sandflies.
  • To assess the impact of mouse immunization with Leishmania antigens on sandfly gut morphology.
  • To investigate the efficacy of recombinant gp63 (rgp63), lipophosphoglycan (LPG), or a cocktail as vaccine candidates.

Main Methods:

  • Mice were immunized with Leishmania major antigens: whole parasite (WPA), rgp63, LPG, or a cocktail.
  • Phlebotomus duboscqi sandflies fed on immunized mice, then dissected at various time points.
  • Sandfly gut morphology was examined using light and transmission electron microscopy; parasite development was assessed.

Main Results:

  • Immunization with WPA, LPG + rgp63 cocktail, and LPG significantly reduced sandfly infection rates.
  • LPG immunization led to a high number of procyclic promastigotes, with nectomonad dominance and few metacyclic forms.
  • Inhibition mechanisms included nectomonad exflagellation and midgut epithelium degeneration in sandflies.

Conclusions:

  • Immune-mediated transmission blocking is a viable strategy for Leishmania infections.
  • Lipophosphoglycan (LPG) demonstrated significant transmission-blocking potential.
  • LPG is a promising candidate for a leishmaniasis transmission-blocking vaccine.